| Bioactivity | sEH inhibitor-3 (compound 35) is a potent and orally active soluble epoxide hydrolase (sEH) inhibitor with a Ki of 0.75 nM for human sEH[1]. |
| Target | Ki: 0.75 nM (Human sEH) |
| Name | sEH inhibitor-3 |
| CAS | 1809885-35-5 |
| Formula | C19H23F4N3O4 |
| Molar Mass | 433.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kin Sing Stephen Lee, et al. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain. Bioorg Med Chem. 2020 Nov 15;28(22):115735. |
sEH inhibitor-3
CAS: 1809885-35-5 F: C19H23F4N3O4 W: 433.40
sEH inhibitor-3 (compound 35) is a potent and orally active soluble epoxide hydrolase (sEH) inhibitor with a Ki of 0.75
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.